The MRC has joined forces with the National Institute for Health Research (NIHR) to create this picture of the dementia research ‘landscape’ in the UK, made up of people working together for a better future for people with dementia. Catherine Moody, MRC Programme Manager for Dementias initiatives, explains what we can see.
The dementias research landscape in the UK can look pretty complicated to those not directly involved in dementias research. It can even look bewildering to those who are!
But as our new picture shows, the jigsaw pieces do fit together. And without any one of the pieces, the picture isn’t complete.
Research published today, funded by the MRC* and the Alzheimer’s Society’s Drug Discovery programme, has made important progress in the search for new treatments for dementia by re-purposing old drugs. Dr Louise Walker, Research Communications Officer at the Alzheimer’s Society, spoke to the scientist who led the research, Professor Giovanna Mallucci at the MRC Toxicology Unit, to find out more.
Alzheimer’s disease and other degenerative brain diseases are characterised by the presence of misfolded proteins in the brain. These proteins are thought to have toxic effects on brain cells, but exactly how they contribute to dementia still remains a mystery.
Today we announced Professor Bart De Strooper will lead the UK’s first Dementia Research Institute (DRI), a combined investment from the MRC, Alzheimer’s Society and Alzheimer’s Research UK. Sara Gregson from the Alzheimer’s Society Research Network, a former carer for her mother with dementia, chaired a recruitment panel involving people affected by dementia. Here she explains the importance of their involvement.
It was an honour for me to be asked to chair the lay interview panel for recruitment of the DRI director. Read more